Asia Pacific Antibiotics & Antimycotics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
The Asia Pacific antibiotics and antimycotics market is projected to grow significantly, reaching approximately US$ 40,545.75 million by 2031, up from US$ 26,570.38 million in 2023, reflecting a compound annual growth rate (CAGR) of 5.4% during the forecast period from 2023 to 2031.
Executive Summary and Market Analysis
The market is divided into several key regions, including China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of this market is primarily driven by the rising incidence of bacterial and fungal infections, such as pneumonia, urinary tract infections (UTIs), sexually transmitted diseases, and skin infections across the region. Additionally, strategic initiatives by market players, including new product launches and approvals, are expected to create lucrative opportunities for market expansion in the coming years.
Market Segmentation
The Asia Pacific antibiotics and antimycotics market can be analyzed through various segments, including drug class, indication, route of administration, and distribution channel:
- Drug Class: The market is categorized into several drug classes, including penicillin, cephalosporins, carbapenems, macrolides, aminoglycosides, quinolones, sulfonamides, tetracyclines, azoles, and others. In 2023, cephalosporins held the largest market share.
- Indication: The market is segmented based on indications such as skin infections, respiratory infections, UTIs, septicemia, ear infections, gastrointestinal infections, and others. Skin infections accounted for the largest share in 2023.
- Route of Administration: The market is divided into oral, topical, and other routes of administration, with oral administration being the most prevalent in 2023.
- Distribution Channel: The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with hospital pharmacies leading the market share in 2023.
Market Outlook
The increasing awareness of fungal infections and their health implications, along with initiatives from both government and private sectors, are significant factors contributing to the growth of the antibiotics and antimycotics market. The Global Action Fund for Fungal Infections (GAFFI) reported that over 300 million people globally suffer from serious fungal diseases, leading to approximately 1.5 million deaths annually, surpassing the combined fatalities from malaria and tuberculosis. This alarming prevalence has prompted enhanced educational efforts and diagnostic initiatives, raising awareness among healthcare providers and patients about the critical need for timely treatment.
Innovations in diagnostic methods, such as molecular testing, have improved the early detection of fungal pathogens, further increasing the demand for effective antifungal treatments. GAFFI's 10-year roadmap for eliminating fungal diseases, established in 2015, outlines essential conditions for effective diagnostic delivery. Various organizations, including the International Society for Human and Animal Mycology (ISHAM) and the European Centre for Disease Prevention and Control (ECDC), are actively working to highlight the burden of fungal infections, promoting prevention, diagnosis, and treatment strategies. The annual Fungal Disease Awareness Week, observed from September 16-20, aims to raise awareness about the growing prevalence of fungal diseases and the need for appropriate responses.
Country Insights
The Asia Pacific antibiotics and antimycotics market is further analyzed by country, with China holding the largest market share in 2023. The country is witnessing a rising prevalence of fungal and bacterial infections, such as UTIs and pneumonia, which drives the demand for antibiotics and antimycotics. According to the Epidemiology and Infection Journal 2023, around 21.1 million individuals in China are affected by community-acquired pneumonia (CAP) annually. Commonly used antibiotics in China include penicillins, fluoroquinolones, cephalosporins, and nitroimidazoles.
Strategic initiatives by market players, including product launches and developments, are expected to create significant growth opportunities. For example, in September 2024, Guangzhou Sino-Israel Bio-Industry Investment Fund 2 LLP invested US$ 6.0 million in BioVersys to support clinical trials in China for BV100, targeting carbapenem-resistant Acinetobacter baumannii. In March 2023, Everest Medicines received a New Drug Application from China's National Medical Products Administration for Xerava (eravacycline) to treat complex intra-abdominal infections in adults.
Company Profiles
Key players in the antibiotics and antimycotics market include Pfizer Inc., Novartis AG, Sanofi SA, F. Hoffmann-La Roche Ltd, Merck & Co Inc., GSK Plc, Johnson & Johnson, Cipla Ltd, Bayer AG, AbbVie Inc., and Astellas Pharma Inc. These companies are employing various strategies, such as expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.
Reason to buy
Executive Summary and Market Analysis
The market is divided into several key regions, including China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The growth of this market is primarily driven by the rising incidence of bacterial and fungal infections, such as pneumonia, urinary tract infections (UTIs), sexually transmitted diseases, and skin infections across the region. Additionally, strategic initiatives by market players, including new product launches and approvals, are expected to create lucrative opportunities for market expansion in the coming years.
Market Segmentation
The Asia Pacific antibiotics and antimycotics market can be analyzed through various segments, including drug class, indication, route of administration, and distribution channel:
- Drug Class: The market is categorized into several drug classes, including penicillin, cephalosporins, carbapenems, macrolides, aminoglycosides, quinolones, sulfonamides, tetracyclines, azoles, and others. In 2023, cephalosporins held the largest market share.
- Indication: The market is segmented based on indications such as skin infections, respiratory infections, UTIs, septicemia, ear infections, gastrointestinal infections, and others. Skin infections accounted for the largest share in 2023.
- Route of Administration: The market is divided into oral, topical, and other routes of administration, with oral administration being the most prevalent in 2023.
- Distribution Channel: The distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with hospital pharmacies leading the market share in 2023.
Market Outlook
The increasing awareness of fungal infections and their health implications, along with initiatives from both government and private sectors, are significant factors contributing to the growth of the antibiotics and antimycotics market. The Global Action Fund for Fungal Infections (GAFFI) reported that over 300 million people globally suffer from serious fungal diseases, leading to approximately 1.5 million deaths annually, surpassing the combined fatalities from malaria and tuberculosis. This alarming prevalence has prompted enhanced educational efforts and diagnostic initiatives, raising awareness among healthcare providers and patients about the critical need for timely treatment.
Innovations in diagnostic methods, such as molecular testing, have improved the early detection of fungal pathogens, further increasing the demand for effective antifungal treatments. GAFFI's 10-year roadmap for eliminating fungal diseases, established in 2015, outlines essential conditions for effective diagnostic delivery. Various organizations, including the International Society for Human and Animal Mycology (ISHAM) and the European Centre for Disease Prevention and Control (ECDC), are actively working to highlight the burden of fungal infections, promoting prevention, diagnosis, and treatment strategies. The annual Fungal Disease Awareness Week, observed from September 16-20, aims to raise awareness about the growing prevalence of fungal diseases and the need for appropriate responses.
Country Insights
The Asia Pacific antibiotics and antimycotics market is further analyzed by country, with China holding the largest market share in 2023. The country is witnessing a rising prevalence of fungal and bacterial infections, such as UTIs and pneumonia, which drives the demand for antibiotics and antimycotics. According to the Epidemiology and Infection Journal 2023, around 21.1 million individuals in China are affected by community-acquired pneumonia (CAP) annually. Commonly used antibiotics in China include penicillins, fluoroquinolones, cephalosporins, and nitroimidazoles.
Strategic initiatives by market players, including product launches and developments, are expected to create significant growth opportunities. For example, in September 2024, Guangzhou Sino-Israel Bio-Industry Investment Fund 2 LLP invested US$ 6.0 million in BioVersys to support clinical trials in China for BV100, targeting carbapenem-resistant Acinetobacter baumannii. In March 2023, Everest Medicines received a New Drug Application from China's National Medical Products Administration for Xerava (eravacycline) to treat complex intra-abdominal infections in adults.
Company Profiles
Key players in the antibiotics and antimycotics market include Pfizer Inc., Novartis AG, Sanofi SA, F. Hoffmann-La Roche Ltd, Merck & Co Inc., GSK Plc, Johnson & Johnson, Cipla Ltd, Bayer AG, AbbVie Inc., and Astellas Pharma Inc. These companies are employing various strategies, such as expansion, product innovation, and mergers and acquisitions, to enhance their market presence and offer innovative solutions to consumers.
Reason to buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antibiotics & antimycotics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific antibiotics & antimycotics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the antibiotics & antimycotics market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
- Pfizer Inc
- Novartis AG
- Sanofi SA
- F. Hoffmann-La Roche Ltd
- Merck & Co Inc
- GSK Plc
- Johnson & Johnson
- Cipla Ltd
- Bayer AG
- AbbVie Inc
- Astellas Pharma Inc
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Increasing Prevalence of Infectious Diseases
4.1.2 Growing Awareness About Fungal Infections
4.2 Market Restraints
4.2.1 Antimicrobial Resistance, Financial Barriers, and Extensive Regulatory Processes
4.3 Market Opportunities
4.3.1 Ongoing Funding and Research & Development Initiatives
4.4 Future Trends
4.4.1 Technological Advancements in Product Development and Treatment Delivery Approaches
4.5 Impact of Drivers and Restraints:
5. ANTIBIOTICS AND ANTIMYCOTICS MARKET - ASIA PACIFIC ANALYSIS
5.1 Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
5.2 Asia Pacific Antibiotics and Antimycotics Market Forecast Analysis
6. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY DRUG CLASS
6.1 Penicillin
6.1.1 Overview
6.1.2 Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Cephalosporines
6.2.1 Overview
6.2.2 Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Carbapenems
6.3.1 Overview
6.3.2 Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 Macrolides
6.4.1 Overview
6.4.2 Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Aminoglycosides
6.5.1 Overview
6.5.2 Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.6 Quinolones
6.6.1 Overview
6.6.2 Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.7 Sulfonamides
6.7.1 Overview
6.7.2 Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.8 Tetracyclines
6.8.1 Overview
6.8.2 Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.9 Azoles
6.9.1 Overview
6.9.2 Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.10 Others
6.10.1 Overview
6.10.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY INDICATION
7.1 Skin Infections
7.1.1 Overview
7.1.2 Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Respiratory Infections
7.2.1 Overview
7.2.2 Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Urinary Tract Infections (UTI)
7.3.1 Overview
7.3.2 Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Septicemia
7.4.1 Overview
7.4.2 Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Ear Infections
7.5.1 Overview
7.5.2 Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Gastrointestinal Infections
7.6.1 Overview
7.6.2 Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY ROUTE OF ADMINISTRATION
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Topical
8.2.1 Overview
8.2.2 Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET - COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific Antibiotics and Antimycotics Market Overview
10.1.2 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
10.1.2.1 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
10.1.2.2 China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.2.1 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.2.2 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.2.3 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.2.4 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.3 Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.3.1 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.3.2 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.3.3 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.3.4 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.4 India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.4.1 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.4.2 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.4.3 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.4.4 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.5 Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.5.1 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.5.2 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.5.3 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.5.4 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.6 South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.6.1 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.6.2 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.6.3 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.6.4 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.7 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.7.1 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.7.2 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.7.3 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.7.4 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
11. ANTIBIOTICS AND ANTIMYCOTICS MARKET - INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Antibiotics and Antimycotics Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Pfizer Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novartis AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sanofi SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck & Co Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GSK Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Johnson & Johnson
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Cipla Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bayer AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 AbbVie Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Astellas Pharma Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Increasing Prevalence of Infectious Diseases
4.1.2 Growing Awareness About Fungal Infections
4.2 Market Restraints
4.2.1 Antimicrobial Resistance, Financial Barriers, and Extensive Regulatory Processes
4.3 Market Opportunities
4.3.1 Ongoing Funding and Research & Development Initiatives
4.4 Future Trends
4.4.1 Technological Advancements in Product Development and Treatment Delivery Approaches
4.5 Impact of Drivers and Restraints:
5. ANTIBIOTICS AND ANTIMYCOTICS MARKET - ASIA PACIFIC ANALYSIS
5.1 Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
5.2 Asia Pacific Antibiotics and Antimycotics Market Forecast Analysis
6. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY DRUG CLASS
6.1 Penicillin
6.1.1 Overview
6.1.2 Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Cephalosporines
6.2.1 Overview
6.2.2 Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Carbapenems
6.3.1 Overview
6.3.2 Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 Macrolides
6.4.1 Overview
6.4.2 Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Aminoglycosides
6.5.1 Overview
6.5.2 Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.6 Quinolones
6.6.1 Overview
6.6.2 Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.7 Sulfonamides
6.7.1 Overview
6.7.2 Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.8 Tetracyclines
6.8.1 Overview
6.8.2 Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.9 Azoles
6.9.1 Overview
6.9.2 Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.10 Others
6.10.1 Overview
6.10.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY INDICATION
7.1 Skin Infections
7.1.1 Overview
7.1.2 Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Respiratory Infections
7.2.1 Overview
7.2.2 Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Urinary Tract Infections (UTI)
7.3.1 Overview
7.3.2 Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Septicemia
7.4.1 Overview
7.4.2 Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Ear Infections
7.5.1 Overview
7.5.2 Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Gastrointestinal Infections
7.6.1 Overview
7.6.2 Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY ROUTE OF ADMINISTRATION
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Topical
8.2.1 Overview
8.2.2 Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET ANALYSIS - BY DISTRIBUTION CHANNEL
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Pharmacies
9.3.1 Overview
9.3.2 Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10. ASIA PACIFIC ANTIBIOTICS AND ANTIMYCOTICS MARKET - COUNTRY ANALYSIS
10.1 Asia Pacific
10.1.1 Asia Pacific Antibiotics and Antimycotics Market Overview
10.1.2 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
10.1.2.1 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country
10.1.2.2 China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.2.1 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.2.2 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.2.3 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.2.4 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.3 Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.3.1 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.3.2 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.3.3 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.3.4 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.4 India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.4.1 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.4.2 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.4.3 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.4.4 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.5 Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.5.1 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.5.2 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.5.3 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.5.4 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.6 South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.6.1 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.6.2 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.6.3 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.6.4 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
10.1.2.7 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
10.1.2.7.1 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class
10.1.2.7.2 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication
10.1.2.7.3 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration
10.1.2.7.4 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel
11. ANTIBIOTICS AND ANTIMYCOTICS MARKET - INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Antibiotics and Antimycotics Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Pfizer Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Novartis AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sanofi SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 F. Hoffmann-La Roche Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck & Co Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GSK Plc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Johnson & Johnson
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Cipla Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bayer AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 AbbVie Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Astellas Pharma Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation
Table 2. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Drug Class
Table 4. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Indication
Table 5. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Route of Administration
Table 6. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Distribution Channel
Table 7. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 8. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 9. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 10. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 11. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 12. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 13. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 14. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 15. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 16. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 17. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 18. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 19. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 20. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 21. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 22. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 23. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 24. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 25. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 26. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 27. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 28. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 29. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 30. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 31. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 32. Recent Organic Growth Strategies in Antibiotics and Antimycotics Market
Table 33. Recent Inorganic Growth Strategies in the Antibiotics and Antimycotics Market
Table 34. Glossary of Terms, Antibiotics and Antimycotics Market
Table 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation
Table 2. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Table 3. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Drug Class
Table 4. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Indication
Table 5. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Route of Administration
Table 6. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Distribution Channel
Table 7. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
Table 8. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 9. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 10. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 11. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 12. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 13. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 14. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 15. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 16. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 17. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 18. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 19. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 20. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 21. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 22. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 23. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 24. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 25. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 26. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 27. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 28. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class
Table 29. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 30. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration
Table 31. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel
Table 32. Recent Organic Growth Strategies in Antibiotics and Antimycotics Market
Table 33. Recent Inorganic Growth Strategies in the Antibiotics and Antimycotics Market
Table 34. Glossary of Terms, Antibiotics and Antimycotics Market
LIST OF FIGURES
Figure 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation - Country
Figure 2. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
Figure 5. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Drug Class (2023 and 2031)
Figure 6. Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 7. Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 13. Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Indication (2023 and 2031)
Figure 17. Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 21. Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 22. Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 23. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 24. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Route of Administration (2023 and 2031)
Figure 25. Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 26. Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 27. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 28. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 29. Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 30. Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 31. Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 32. Asia Pacific Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 33. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 34. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 35. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 36. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 37. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 38. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 39. Growth Strategies in Antibiotics and Antimycotics Market
Figure 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation - Country
Figure 2. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031
Figure 5. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Drug Class (2023 and 2031)
Figure 6. Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 7. Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 8. Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 9. Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 10. Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 11. Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 12. Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 13. Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 14. Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 15. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 16. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Indication (2023 and 2031)
Figure 17. Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 18. Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 19. Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 20. Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 21. Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 22. Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 23. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 24. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Route of Administration (2023 and 2031)
Figure 25. Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 26. Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 27. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 28. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Distribution Channel (2023 and 2031)
Figure 29. Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 30. Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 31. Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)
Figure 32. Asia Pacific Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 33. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 34. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 35. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 36. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 37. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 38. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)
Figure 39. Growth Strategies in Antibiotics and Antimycotics Market
